Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hemofiltration in chronic heart failure].

D H Glogar, H K Stummvoll, P Wittels

    Acta Medica Austriaca
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nuclear Astrophysics in the Storage Ring: Background Suppressed Simultaneous Measurement of (p,γ) and (p,n) Reactions.

    Physical review letters·2025
    Same author

    Shedding Light on the Origin of ^{204}Pb, the Heaviest s-Process-Only Isotope in the Solar System.

    Physical review letters·2024
    Same author

    [Neural networks in addiction].

    Tijdschrift voor psychiatrie·2024
    Same author

    <math></math> Ge( <math></math> ) cross section below 70 keV measured at n_TOF CERN.

    The European physical journal. A, Hadrons and nuclei·2022
    Same author

    Rapid organocatalytic chirality analysis of amines, amino acids, alcohols, amino alcohols and diols with achiral iso(thio)cyanate probes.

    Chemical science·2021
    Same author

    Neutron Capture on the s-Process Branching Point ^{171}Tm via Time-of-Flight and Activation.

    Physical review letters·2020
    Same journal

    [Gestational diabetes mellitus].

    Acta medica Austriaca·2005
    Same journal

    [Diagnosis, therapy and follow-up of diabetic eye diseases].

    Acta medica Austriaca·2005
    Same journal

    [Diabetic nephropathy].

    Acta medica Austriaca·2005
    Same journal

    [The diabetic foot].

    Acta medica Austriaca·2005
    Same journal

    [Diabetic neuropathy].

    Acta medica Austriaca·2005
    Same journal

    [Inhibition of platelet aggregation].

    Acta medica Austriaca·2005
    See all related articles

    Continuous hemofiltration (CHF) effectively reduced fluid overload and improved hemodynamics in severe heart failure patients. Patients with low sodium levels experienced the most significant benefits from this fluid removal therapy.

    Area of Science:

    • Nephrology
    • Cardiology
    • Critical Care Medicine

    Context:

    • Severe congestive heart failure (NYHA IV) often presents challenges in medical management.
    • Fluid overload is a common and critical complication in advanced heart failure.
    • Patients unresponsive to conventional therapies require alternative treatment strategies.

    Purpose:

    • To evaluate the efficacy of continuous hemofiltration (CHF) in managing severe, medically refractory congestive heart failure.
    • To assess the impact of CHF on fluid balance, hemodynamic parameters, and clinical outcomes.
    • To identify patient subgroups that may benefit most from CHF therapy.

    Summary:

    • Thirty patients with NYHA IV congestive heart failure underwent arteriovenous or venovenous CHF for approximately 95 hours.

    Related Experiment Videos

  • Fluid removal (2-40 kg) resulted in reduced edema and short-term clinical improvement.
  • Hemodynamic improvements included significant reductions in central venous pressure and left ventricular filling pressure, with unchanged left ventricular ejection fraction.
  • Patients with lower serum sodium levels (<132 mEq/L) showed the greatest benefit.
  • 28/30 patients experienced short-term improvement, and 38% showed long-term benefits.

    • Impact:

    • Continuous hemofiltration offers a viable therapeutic option for fluid management in severe congestive heart failure.
    • CHF can lead to significant hemodynamic stabilization and symptomatic relief in refractory cases.
    • The findings highlight the potential of CHF as a supportive therapy to improve outcomes in advanced heart failure patients.